Clinical Trials Browser

Phase 2 × INDUSTRY × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all

NCT07301229 2025-12-24

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)